Strativa Pharmaceuticals is the proprietary products division of Par Pharmaceutical Companies, Inc. We are bringing to market novel, proprietary products by applying innovative technologies, reformulation techniques and delivery systems to enhance their performance.

• Launched in 2005 as Par Pharmaceutical Companies, Inc.’s Proprietary Products Division, renamed Strativa Pharmaceuticals in 2007
• Our mission is to improve molecules for specific patient populations whose needs aren’t being met by existing products, so their overall treatment experience is improved
• In preparation for our dual launch, we are expanding our sales force by 60, now employing over 250 professionals
• Successes to date include the reformulation and launch of Megace® ES, the relaunch of Nascobal Nasal Spray and the acceptance of new drug applications for ondansetron oral soluble film and miconazole buccal tablets
• Solid infrastructure of marketing, sales, legal, regulatory, managed care, and medical affairs to help prepare a product for launch and beyond